An Analog of MIF, Alaptide: Effect on Serum Prolactin, Dopamine Receptors and Growth of Rat Adenohypophysis
Authors:
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Endocrine Research
- Vol. 20 (1) , 39-46
Abstract
Alaptide is a drug chemically derived from prolyl-leucyl-glycin amide (PLG) which is effective after oral administration. We studied the effect of long term treatment with alaptide and estradiol-benzoate on serum prolactin, growth reactivity and dopamine DA-2 receptors in the anterior pituitary of male rats. Alaptide reduced adenohypophyseal weight when given alone, but only nonsignificantly reduced growth reactivity of the anterior pituitary (AP) raised by estradiol-benzoate (EB). Alaptide significantly decreased the serum level of prolactin but, on the other hand, significantly increased the binding of 3H-spiperone to dopamine DA-2 receptors in AP membrane preparations, without affecting affinity. The administration of alaptide plus EB together resulted in an additional increase of dopamine DA-2 binding sites. We assume that alaptide has a weak dopaminergic activity on the AP of male rats.Keywords
This publication has 4 references indexed in Scilit:
- Evidence of an EGF/TGF‐α—independent pathway for estrogen‐regulated cell proliferationJournal of Cellular Biochemistry, 1991
- AlaptideDrugs of the Future, 1990
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Effect of Oestrin on Ovaries and AdrenalsExperimental Biology and Medicine, 1935